StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Ironwood Pharmaceuticals's ebitda for the twelve months ending Dec 31, 2018 was -$146.77M. For fiscal 2025 it was $99.60M, up 5.6% from the year before. The highest annual figure on record is $251.74M in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$99.60M+5.6%
FY2024Dec 31, 2024$94.32M–
FY2023Dec 31, 2023-$944.23M-475.1%
FY2022Dec 31, 2022$251.74M+7.7%
FY2021Dec 31, 2021$233.76M+60.9%
FY2020Dec 31, 2020$145.24M+15.5%
FY2019Dec 31, 2019$125.72M–
FY2018Dec 31, 2018-$146.77M–
FY2017Dec 31, 2017-$8.96M–
FY2016Dec 31, 2016-$41.59M–
FY2015Dec 31, 2015-$90.46M–
FY2014Dec 31, 2014-$157.04M–
FY2013Dec 31, 2013-$240.27M–
FY2012Dec 31, 2012-$61.44M–
FY2011Dec 31, 2011-$56.14M–
FY2010Dec 31, 2010-$54.61M–
FY2009Dec 31, 2009-$56.05M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2018Dec 31, 2018$28.91M-65.8%
Q3 FY2018Sep 30, 2018-$145.19M–
Q2 FY2018Jun 30, 2018-$13.01M–
Q1 FY2018Mar 31, 2018-$34.08M–
Q4 FY2017Dec 31, 2017$84.59M–
Q3 FY2017Sep 30, 2017-$17.67M–
Q2 FY2017Jun 30, 2017-$39.08M–
Q1 FY2017Mar 31, 2017-$36.80M–
Q4 FY2016Dec 31, 2016-$3.54M–
Q3 FY2016Sep 30, 2016-$26.09M–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?